Conivog-MG3 Tablet SR
By Conivog MG
Rx
10 Tablet SR in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg) + Voglibose(0.3mg)

Manufacturer - Novalab Healthcare Pvt Ltd
Scf 263, 2nd Floor, Motor Market Manimajra, Chandigarh - 160101, India

Expires on or after
November, 2025

liver
When using Conivog-MG3 Tablet SR, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking this medication, so it's crucial to consult your doctor before starting treatment. Typically, Conivog-MG3 Tablet SR is initiated at a low dose for individuals with mild to moderate liver disease. However, it is not advised for use in patients with severe liver disease. Be sure to seek guidance from your healthcare provider to ensure the safe and appropriate use of Conivog-MG3 Tablet SR.

kidney
Conivog-MG3 Tablet SR may not be safe for patients with kidney disease. It is advised to avoid using this medication if you have kidney issues. Please consult your doctor before taking Provog GM Tablet SR, especially if you have severe kidney disease.

alcohol
It is not safe to drink alcohol while taking Conivog-MG3 Tablet SR.

driving
It is important to note that your driving ability may be impacted if you experience low or high blood sugar levels while taking Conivog-MG3 Tablet SR. It is advisable to avoid driving in such situations.

pregnancy
Conivog-MG3 Tablet SR may not be safe to use during pregnancy. Animal studies indicate potential harm to the baby's development. Your doctor will assess the risks versus benefits before prescribing. Consulting your doctor is advised.

breastfeeding
Conivog-MG3 Tablet SR is likely unsafe during breastfeeding as it may pass into breastmilk and harm the baby based on limited data.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹120
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024